Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
Ahmed Saleh BarefahOsman O RadhwiSawsan S AlamriHatem M AlahwalIuliana DenetiuAbdullah T AlmohammadiSalem M BahashwanMohamad H QariAbdullah AlgaissiEdrous AlamerAbdulaziz AlhazmiAdel M AbuzenadahWalleed H NasraldeenSami H AlzahraniAnwar M HashemPublished in: International journal of laboratory hematology (2021)
Our results provide new evidence to guide the diagnostic algorithm of suspected cases of VITT. In the absence of thrombosis and thrombocytopenia, there is a low utility of testing for anti-PF4 antibodies.